{
    "Trade/Device Name(s)": [
        "AxSYM\u00ae Digoxin III"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K061249",
    "Predicate Device Reference 510(k) Number(s)": [
        "K953718"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KXT",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "May 3, 2006",
    "Summary Letter Received Date": "May 4, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3320"
    ],
    "Regulation Name(s)": [
        "Digoxin test system"
    ],
    "Analyte Class(es)": [
        "toxicology",
        "tdm"
    ],
    "Analyte(s)": [
        "Digoxin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Abbott AxSYM Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Microparticle enzyme immunoassay (MEIA)"
    ],
    "Methodologies": [
        "Enzyme immunoassay",
        "Competitive immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent",
        "Probe Wash Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott AxSYM Digoxin III quantitative MEIA assay for measurement of digoxin in serum or plasma",
    "Indications for Use Summary": "Quantitative measurement of digoxin in serum or plasma for treatment of digoxin overdose and monitoring of digoxin therapy",
    "fda_folder": "Toxicology"
}